Kyasanur forest disease: a state-of-the-art review.
Gupta N, Wilson W, Neumayr A, Saravu K.
QJM. 2022 Jun 7;115(6):351-358. doi: 10.1093/qjmed/hcaa310.
Kyasanur Forest Disease: A Comprehensive Review.
N S, Kandi V, G SR, Ca J, A H, As A, Kapil C, Palacholla PS.
Cureus. 2024 Jul 23;16(7):e65228. doi: 10.7759/cureus.65228. eCollection 2024 Jul.
Kyasanur Forest Disease in India: innovative options for intervention.
Rajaiah P.
Hum Vaccin Immunother. 2019;15(10):2243-2248. doi: 10.1080/21645515.2019.1602431. Epub 2019 May 7.
Kyasanur forest disease.
Holbrook MR.
Antiviral Res. 2012 Dec;96(3):353-62. doi: 10.1016/j.antiviral.2012.10.005. Epub 2012 Oct 27.
Kyasanur Forest Disease and Alkhurma Hemorrhagic Fever Virus-Two Neglected Zoonotic Pathogens.
Bhatia B, Feldmann H, Marzi A.
Microorganisms. 2020 Sep 12;8(9):1406. doi: 10.3390/microorganisms8091406.
Clinical & epidemiological significance of Kyasanur forest disease.
Munivenkatappa A, Sahay RR, Yadav PD, Viswanathan R, Mourya DT.
Indian J Med Res. 2018 Aug;148(2):145-150. doi: 10.4103/ijmr.IJMR_688_17.
Kyasanur forest disease and climatic attributes in India.
Singh P, Kumar P, Dhiman RC.
J Vector Borne Dis. 2022 Jan-Mar;59(1):79-85. doi: 10.4103/0972-9062.331408.
Historical Expansion of Kyasanur Forest Disease in India From 1957 to 2017: A Retrospective Analysis.
Chakraborty S, Andrade FCD, Ghosh S, Uelmen J, Ruiz MO.
Geohealth. 2019 Feb 5;3(2):44-55. doi: 10.1029/2018GH000164. eCollection 2019 Feb.
Does the rise in cases of Kyasanur forest disease call for the implementation of One Health in India?
Pattnaik S, Agrawal R, Murmu J, Kanungo S, Pati S.
IJID Reg. 2023 Feb 12;7:18-21. doi: 10.1016/j.ijregi.2023.02.003. eCollection 2023 Jun.
Kyasanur Forest disease virus non-mouse animal models: a pilot study.
Nikiforuk AM, Tierny K, Cutts TA, Kobasa DK, Theriault SS, Cook BWM.
BMC Res Notes. 2020 Jun 15;13(1):291. doi: 10.1186/s13104-020-05137-8.
